Public Citizen Demands Investigation into "Inappropriate Collaboration" Between FDA and Biogen Over Alzheimer's Drug

The consumer’s group Public Citizen demanded the Office of the Inspector General (OIG) for the U.S. Department of Health and Human Services (HHS) conduct an investigation into “inappropriate collaboration” between the U.S. Food and Drug Administration (FDA) and Biogen over the company’s submission for Alzheimer’s drug aducanumab.